Bioidentical Hormones - U.S. Senate Special Committee on Aging
Bioidentical Hormones - U.S. Senate Special Committee on Aging
Bioidentical Hormones - U.S. Senate Special Committee on Aging
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
212<br />
,mucmai rimi &r<strong>on</strong>os farty bstrogen kreventi<strong>on</strong> Study (KEEPS)<br />
CfinicalTrials.gov in, _<br />
Hpmne Scorch I , e j<br />
WhaN<br />
Purpose<br />
Kr<strong>on</strong>os Early Estrogen Preventi<strong>on</strong> Study (KEEPS)<br />
This study is currently recruiting patients.<br />
Verified by Krnor Lmgffevity Kearch IfitsIte May 2006<br />
Sp<strong>on</strong>sors and Collaborators: Kr<strong>on</strong>os L<strong>on</strong>gevity Research Institute<br />
Albert Einstein College of Medicine<br />
Brigham and Women's Hospital<br />
Columbia Presbyterian Medical Center<br />
Mayo Clinic<br />
University of California, San Francisco<br />
University of Utah<br />
University of Washingt<strong>on</strong><br />
Yale University<br />
Informati<strong>on</strong> provided by: Kr<strong>on</strong>os L<strong>on</strong>gevity Research Institute<br />
CllnicalTrialshgov Identifier. NCT00154180<br />
I<br />
ra MkSIWC*<br />
The study will examine the effects of estrogen and progester<strong>on</strong>e <strong>on</strong> the development of atherosclerosis in<br />
menopausal women when horm<strong>on</strong>e treatment is initiated within 3 years of the menopausal transiti<strong>on</strong><br />
C<strong>on</strong>dtti<strong>on</strong> Interventt<strong>on</strong> Phan<br />
Menopause Drug: C<strong>on</strong>jugated equine estrogens 0.45 mg/day<br />
Arteriosclerosis Drug: Transdermal estradiol. 50 mcg/day<br />
Drug: Micr<strong>on</strong>ized progester<strong>on</strong>e, 200 mg/day x 12 d/m<strong>on</strong>th<br />
Me4linePlus related topics: YaseulutDieasesw<br />
Qenetielm oe Reference related topics: Vascular Diseags<br />
Study Type: Interventi<strong>on</strong>al<br />
Study Design: Preventi<strong>on</strong>, Randomized, Double-Blind, Placebo C<strong>on</strong>trol, Parallel Assignment,<br />
Safety/Efficscy Study<br />
Official Title: Effects of Estrogen Replacement <strong>on</strong> Atherosclerosis Progressi<strong>on</strong> in Recently Menopausal Women<br />
Further study details as provided by Kr<strong>on</strong>os L<strong>on</strong>gevity Research Institute:<br />
Prinary Outcomes: Rate of change of carotid intimal medial thickness by ultrasound<br />
Sec<strong>on</strong>dary Outcomes: Change in cor<strong>on</strong>aty calcium score by X-ray tomography; Plasma lipid profiles;<br />
Blood clotting factors, Serum inflammatory factors; Horm<strong>on</strong>e levels; Cognitive and Affective scores <strong>on</strong><br />
standard psychometric tests; Quality of life<br />
Expected Total Enrollment: 720<br />
.-11.._._.I;.. _1:_:__11_. -,.0--W.h.A Y I Al I QfAI74-AA<br />
'"drcui<br />
Annnnn~f7